BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2023 3:41:16 PM | Browse: 402 | Download: 1100
 |
Received |
|
2022-12-28 03:10 |
|
Peer-Review Started |
|
2022-12-28 03:11 |
|
First Decision by Editorial Office Director |
|
2023-01-05 08:47 |
|
Return for Revision |
|
2023-01-05 08:47 |
|
Revised |
|
2023-01-13 07:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-02-08 03:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-02-09 00:42 |
|
Articles in Press |
|
2023-02-09 00:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-09 10:36 |
|
Publish the Manuscript Online |
|
2023-03-15 15:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hiroshi Nomoto |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hiroshi Nomoto, MD, PhD, Assistant Professor, Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo 060-8638, Hokkaido, Japan. hnomoto@med.hokudai.ac.jp |
| Key Words |
Clinical trial; Diabetes mellitus, type 2; Glucagon-like peptide-1 receptor; Glycemic control; Insulin, long-acting; Quality of life |
| Core Tip |
Fixed-ratio combination injections comprising basal insulin and glucagon-like peptide-1 receptor agonists are now available, and their efficacy for glycemic control has been demonstrated in several phase II/III trials. These injections appear to be useful based on the trial data, but real-world clinical evidence regarding the use of these compounds is limited. In this review, the clinical evidence derived from phase III and real-world clinical studies regarding the glycemic control of and other outcomes in participants with type 2 diabetes is summarized. |
| Publish Date |
2023-03-15 15:41 |
| Citation |
Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2024; In press |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i3/188.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i3.188 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
